Harbin Pharmaceutical Group Co Ltd (600664) — Capital Reinvestment Ratio
Harbin Pharmaceutical Group Co Ltd (600664) has a Capital Reinvestment Ratio of 0.06x as of June 2025, meaning it reinvests 0% of its operating cash flow (CN¥323.33 Million) in capital expenditures (CN¥20.49 Million). See 600664 equity financing ratio to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Harbin Pharmaceutical Group Co Ltd Capital Reinvestment Ratio (1998–2024)
This chart tracks Harbin Pharmaceutical Group Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Check how aggressively does Harbin Pharmaceutical Group Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year Capital Reinvestment Ratio for Harbin Pharmaceutical Group Co Ltd from 1998 to 2024. For live market cap and broader valuation context, see market cap of Harbin Pharmaceutical Group Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | CN¥792.50 Million | CN¥100.81 Million | ▲ +39.6% |
| 2023 | 0.09x | CN¥949.67 Million | CN¥86.54 Million | ▼ -36.8% |
| 2022 | 0.14x | CN¥622.09 Million | CN¥89.65 Million | ▼ -12.5% |
| 2018 | 0.16x | CN¥692.72 Million | CN¥114.11 Million | ▼ -75.9% |
| 2017 | 0.68x | CN¥149.22 Million | CN¥102.01 Million | ▲ +1667.3% |
| 2016 | 0.04x | CN¥2.78 Billion | CN¥107.46 Million | ▼ -77.9% |
| 2015 | 0.18x | CN¥1.66 Billion | CN¥290.75 Million | ▼ -47.0% |
| 2014 | 0.33x | CN¥1.14 Billion | CN¥375.37 Million | ▼ -87.3% |
| 2013 | 2.61x | CN¥141.64 Million | CN¥369.90 Million | ▲ +428.2% |
| 2012 | 0.49x | CN¥557.83 Million | CN¥275.78 Million | ▲ +90.5% |
| 2010 | 0.26x | CN¥1.15 Billion | CN¥299.19 Million | ▲ +115.3% |
| 2009 | 0.12x | CN¥1.85 Billion | CN¥223.26 Million | ▼ -51.2% |
| 2008 | 0.25x | CN¥578.59 Million | CN¥143.09 Million | ▼ -8.1% |
| 2007 | 0.27x | CN¥650.16 Million | CN¥175.00 Million | ▼ -39.1% |
| 2006 | 0.44x | CN¥738.08 Million | CN¥326.28 Million | ▼ -24.5% |
| 2005 | 0.59x | CN¥757.76 Million | CN¥443.61 Million | ▼ -79.6% |
| 2004 | 2.88x | CN¥149.01 Million | CN¥428.60 Million | ▲ +83.9% |
| 2003 | 1.56x | CN¥302.83 Million | CN¥473.73 Million | ▲ +53.4% |
| 2002 | 1.02x | CN¥383.44 Million | CN¥391.03 Million | ▼ -3.0% |
| 2001 | 1.05x | CN¥604.13 Million | CN¥635.28 Million | ▼ -2.2% |
| 2000 | 1.08x | CN¥541.70 Million | CN¥582.49 Million | ▲ +151.4% |
| 1999 | 0.43x | CN¥431.22 Million | CN¥184.43 Million | ▼ -6.0% |
| 1998 | 0.45x | CN¥221.41 Million | CN¥100.73 Million | — |